EFFETS THÉRAPEUTIQUES DES BRYOSTATINES, BRYOLOGUES ET AUTRES SUBSTANCES APPARENTÉES SUR LES TROUBLES DE LA MÉMOIRE ET LES LÉSIONS CÉRÉBRALES SUITE À UN TRAUMATISME CRÂNIEN
The invention provides for the use of protein kinase activators or boosters of nerve growth factor (NGF), brainderived neurotrophic factor (BDNF) or other neurotrophic factors to treat head trauma. Specifically, the present invention provides methods of treating head trauma comprising the steps of identifying a subject having suffered a head trauma and administering to said subject an amount of a pharmaceutical composition comprising a protein kinase C (PKC) activator or 4-methylcatechol acetic acid (MCBA) and a pharmaceutically acceptable carrier effective to treat at least one symptom of head trauma.
